Carbon-ion beams induce production of an immune mediator protein, high mobility group box 1, at levels comparable with X-ray irradiation

Journal of Radiation Research
Yuya YoshimotoTakashi Nakano

Abstract

X-ray radiotherapy activates tumor antigen-specific T-cell responses, and increases in the serum levels of high mobility group box 1 (HMGB1) induced by X-ray irradiation play a pivotal role in activating anti-tumor immunity. Here, we examined whether carbon-ion beams, as well as X-rays, can induce HMGB1 release from human cancer cell lines. The study examined five human cancer cell lines: TE2, KYSE70, A549, NCI-H460 and WiDr. The proportion of cells surviving X- or carbon-ion beam irradiation was assessed in a clonogenic assay. The D10, the dose at which 10% of cells survive, was calculated using a linear-quadratic model. HMGB1 levels in the culture supernatants were assessed by an ELISA. The D10 dose for X-rays in TE2, KYSE70, A549, NCI-H460 and WiDr cells was 2.1, 6.7, 8.0, 4.8 and 7.1 Gy, respectively, whereas that for carbon-ion beams was 0.9, 2.5, 2.7, 1.8 and 3.5 Gy, respectively. X-rays and carbon-ion beams significantly increased HMGB1 levels in the culture supernatants of A549, NCI-H460 and WiDr cells at 72 h post-irradiation with a D10 dose. Furthermore, irradiation with X-rays or carbon-ion beams significantly increased HMGB1 levels in the culture supernatants of all five cell lines at 96 h post-irradiation. There wa...Continue Reading

References

Feb 1, 1982·International Journal of Radiation Oncology, Biology, Physics·H D ThamesG H Fletcher
Feb 15, 2001·International Journal of Radiation Oncology, Biology, Physics·M BaumannH D Thames
Apr 13, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takashi NakanoHirohiko Tsujii
Jan 7, 2009·Current Opinion in Oncology·Oliver KeppGuido Kroemer
Apr 14, 2009·International Journal of Radiation Oncology, Biology, Physics·Tomoaki TamakiTakashi Imai
Feb 4, 2010·Biochimica Et Biophysica Acta·Daolin TangMichael T Lotze
Mar 3, 2010·Annual Review of Immunology·Gary P SimsAnthony J Coyle
May 29, 2010·Journal of Radiation Research·Tohru OkadaHirohiko Tsujii
Aug 21, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Yong LiuYuanzheng Qiu
Feb 9, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jennifer L GuerrieroWei-Xing Zong
Sep 29, 2011·The Cancer Journal·Dalil HannaniLaurence Zitvogel
Mar 9, 2012·The New England Journal of Medicine·Michael A PostowJedd D Wolchok
May 9, 2012·International Journal of Radiation Oncology, Biology, Physics·Emily F StamellIsaac Brownell
Jul 17, 2012·Japanese Journal of Clinical Oncology·Hirohiko Tsujii, Tadashi Kamada
May 21, 2013·Oncoimmunology·Erika VacchelliLorenzo Galluzzi
Jun 1, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rui KangDaolin Tang
Jul 19, 2013·The Journal of Clinical Investigation·Anusha KalbasiNeha Vapiwala
Sep 21, 2013·Cancer Immunology, Immunotherapy : CII·Benjamin FreyUdo S Gaipl
Dec 10, 2013·Oncoimmunology·Erika VacchelliLorenzo Galluzzi

❮ Previous
Next ❯

Citations

Feb 24, 2016·Frontiers in Oncology·Kathryn D HeldAkihisa Takahashi
Jul 3, 2015·Fukushima Journal of Medical Science·Yuya YoshimotoYoshiyuki Suzuki
Mar 9, 2020·Radiation and Environmental Biophysics·K E ApplegateS Bouffler
Apr 5, 2020·International Journal of Clinical Oncology·Hiro SatoTakashi Nakano
Mar 10, 2017·Frontiers in Immunology·Rodrigo Fernandez-GonzaloMarjan Moreels
Jun 24, 2017·Frontiers in Immunology·Sebastian Diegeler, Christine E Hellweg
Jul 1, 2016·International Journal of Particle Therapy·Takashi ShimokawaTakashi Imai
Jan 16, 2021·The Urologic Clinics of North America·Sujit S NairAshutosh K Tewari
Feb 28, 2018·International Journal of Radiation Oncology, Biology, Physics·Radhe MohanJacek Capala
Feb 22, 2021·Seminars in Radiation Oncology·Peter H GoffStephanie K Schaub
May 1, 2021·Cells·Rianne D W VaesDirk De Ruysscher
Jul 1, 2021·Scientific Reports·Céline MirjoletHélène Burckel
Sep 29, 2021·Journal of Hematology & Oncology·Shaoming ZhuChong-Xian Pan

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
FCS
ELISA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.